Ken Coleman
Impact in
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antibiotic Resistance in Bacteria 7
-
- Antibiotics Pharmacokinetics and Efficacy 5
- Co-authors
- Christine Miossec (2 shared papers)Anne-Marie Girard (2 shared papers)Premavathy Levasseur (2 shared papers)John Pace (1 shared paper)George L. Drusano (1 shared paper)Monica Borgonovi (1 shared paper)Henri Merdjan (1 shared paper)David M. Shlaes (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (4 papers)Nature Biotechnology (2 papers)Current Opinion in Microbiology (1 paper)Journal of Antimicrobial Chemotherapy (1 paper)Expert Opinion on Investigational Drugs (1 paper)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Ken Coleman
12 papers receiving 442 citations
Peers
Comparison fields: 5 of 55
- Molecular Medicine 307
- Applied Microbiology and Biotechnology 69
- Pharmacology 200
- Endocrinology 25
- Epidemiology 119
Countries citing papers authored by Ken Coleman
This map shows the geographic impact of Ken Coleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Coleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Coleman more than expected).
Fields of papers citing papers by Ken Coleman
This network shows the impact of papers produced by Ken Coleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Coleman. The network helps show where Ken Coleman may publish in the future.
Co-authors
The 25 scholars most cited alongside Ken Coleman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 200 | |
| 2 | 2014 | 79 | |
| 3 | 2015 | 50 | |
| 4 | 1994 | 36 | |
| 5 | 2013 | 30 | |
| 6 | 2004 | 26 | |
| 7 | 1995 | 13 | |
| 8 | 2014 | 8 | |
| 9 | 2007 | 8 | |
| 10 | 2006 | 6 | |
| 11 | 1989 | 2 | |
| 12 | 1989 | 1 |
About Ken Coleman
Ken Coleman is a scholar working on Molecular Medicine, Pharmacology, Infectious Diseases, Molecular Biology and Pollution, having authored 12 papers that have together received 459 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (7 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Phenothiazines and Benzothiazines Synthesis and Activities (2 papers), Antibiotic Use and Resistance (2 papers), Pharmaceutical and Antibiotic Environmental Impacts (2 papers), Meat and Animal Product Quality (1 paper), Antifungal resistance and susceptibility (1 paper) and Biopolymer Synthesis and Applications (1 paper). The work is most often cited by research in Molecular Medicine (307 citations), Applied Microbiology and Biotechnology (69 citations), Pharmacology (200 citations), Endocrinology (25 citations) and Epidemiology (119 citations). Ken Coleman has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Christine Miossec, Anne-Marie Girard, Premavathy Levasseur, John Pace, George L. Drusano, Monica Borgonovi, Henri Merdjan, David M. Shlaes, Wright W. Nichols and M. Athalye. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Nature Biotechnology, Current Opinion in Microbiology, Journal of Antimicrobial Chemotherapy and Expert Opinion on Investigational Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.